z-logo
open-access-imgOpen Access
Frequent Large GermlineHRPT2Deletions in a French National Cohort of Patients With Primary Hyperparathyroidism
Author(s) -
Léopoldine Bricaire,
MarieFrançoise Odou,
Catherine Cardot-Bauters,
Brigitte Delemer,
Marie-Odile North,
Sylvie Salenave,
Delphine Vezzosi,
JeanMarc Kuhn,
Arnaud Murat,
Philippe Caron,
JeanLouis Sadoul,
Caroline Silve,
Philippe Chanson,
Anne Barlier,
Éric Clauser,
Nicole Porchet,
Lionel Groussin
Publication year - 2013
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-2789
Subject(s) - primary hyperparathyroidism , penetrance , germline mutation , point mutation , gene mutation , gastroenterology , biology , hyperparathyroidism , pathology , medicine , genetics , mutation , gene , phenotype
Hyperparathyroidism-jaw tumor syndrome (HPT-JT) is an autosomal dominant syndrome with incomplete penetrance that can associate in a single patient parathyroid adenoma or carcinoma, fibro-osseous jaw tumor, cystic kidney lesion, and uterine tumor. Germline mutations of the HRPT2 gene (CDC73) coding for parafibromin are identified in approximately 50%-75% of HPT-JT cases and in approximately 14% of familial isolated hyperparathyroidism. A whole deletion of this gene has recently been reported in 1 sporadic case and in a family presenting with HPT-JT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom